Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-13,665
Closed -$1.69M 61
2014
Q1
$1.69M Sell
13,665
-737,418
-98% -$89.4M 0.01% 794
2013
Q4
$85.7M Buy
751,083
+687,800
+1,087% +$78.2M 0.5% 43
2013
Q3
$7.08M Buy
63,283
+41,304
+188% +$4.48M 0.04% 455
2013
Q2
$2.17M Buy
+21,979
New +$2.28M 0.01% 734

Other funds holding AMGN

SAC Capital Advisors's AMGN Position: Q2 2014 in Review

SAC Capital Advisors sold out of Amgen (AMGN) in Q2 2014, closing a stake of 13,665 shares — an estimated $1.69M sold.

SAC Capital Advisors first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $85.7M in Q4 2013. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

  • SAC Capital Advisors reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 13,665 Amgen shares in Q2 2014, an estimated $1.69M.
  • SAC Capital Advisors first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Amgen position peaked at $85.7M in Q4 2013.
  • 1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.